IBL HealthCare Limited's latest marketcap:
As of 06/27/2025, IBL HealthCare Limited's market capitalization has reached $18.91 M. According to our data, IBL HealthCare Limited is the 36478th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 18.91 M |
| Revenue (ttm) | 12.4 M |
| Net Income (ttm) | -135,414.53 |
| Shares Out | 85.67 M |
| EPS (ttm) | 0 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | 10/03/2025 |
IBL HealthCare Limited's yearly market capitalization.
| Date | Market Cap | Change (%) | Global Rank |
|---|---|---|---|
| 06/27/2025 | rs18.91 M | 35.62% | 36478 |
| 12/31/2024 | rs3.53 B | 13.78% | 36888 |
| 12/29/2023 | rs3.1 B | 15.6% | 36751 |
| 12/30/2022 | rs2.68 B | -41% | 35298 |
| 12/31/2021 | rs4.55 B | -27.03% | 31476 |
| 12/31/2020 | rs6.24 B | 54.12% | 26183 |
| 12/31/2019 | rs4.05 B | 49.72% | 25257 |
| 12/31/2018 | rs2.7 B | -41.91% | 25572 |
| 12/29/2017 | rs4.65 B | -44.41% | 22437 |
| 12/30/2016 | rs8.37 B | 111.8% | 17017 |
Company Profile
About IBL HealthCare Limited
IBL HealthCare Limited is a leading company engaged in the marketing, selling, and distribution of healthcare and pharmaceutical products across Pakistan. Established in 1997 and headquartered in Karachi, the company operates as a subsidiary of The Searle Company Limited.
Product Portfolio
IBL HealthCare offers a diverse range of healthcare solutions, including:
- Nutritional Products: Toddler foods, baby cereals, infant formulas, medical and lifestyle nutrition, and specialty nutrition products.
- Hygiene & Safety: Consumer health products and vision care solutions.
- Renal Care: Hollow fiber dialyzers, hemodialysis tubing sets, double lumen catheter kits, and disposable AV fistula needles.
- Critical Care & Anesthesia: Meditech connectors, circuits, filters, anesthesia masks, and oxygen therapy products.
- Surgical & Medical Supplies: Examination gloves, blood transfusion sets, IV administration products, surgical tapes, and urine collection bags.
- Respiratory & Neonatal Care: Nebulizer masks, nasal oxygen cannulas, infant feeding tubes, and suction catheters.
With a commitment to quality and innovation, IBL HealthCare continues to serve the healthcare needs of Pakistan effectively.
Frequently Asked Questions
-
What is IBL HealthCare Limited's (PSX-IBLHL) current market cap?As of 06/27/2025, IBL HealthCare Limited (including the parent company, if applicable) has an estimated market capitalization of $18.91 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does IBL HealthCare Limited (PSX-IBLHL) rank globally by market cap?IBL HealthCare Limited global market capitalization ranking is approximately 36478 as of 06/27/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.